<div id="readability-page-1"><div><p>The United States market remained flat over the last week but has seen a notable 30% increase over the past year, with earnings forecasted to grow by 16% annually. In such an environment, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and alignment with shareholder interests.</p><h3>Top 10 Growth Companies With High Insider Ownership In The United States</h3><div><table><tbody><tr><td><strong>Name</strong></td><td><strong>Insider Ownership</strong></td><td><strong>Earnings Growth</strong></td></tr><tr><td>Uxin (UXIN)</td><td>35.7%</td><td>74.1%</td></tr><tr><td>Upstart Holdings (UPST)</td><td>12.8%</td><td>53.6%</td></tr><tr><td>Precigen (PGEN)</td><td>11.9%</td><td>68.4%</td></tr><tr><td>Karman Holdings (KRMN)</td><td>17%</td><td>53.2%</td></tr><tr><td>Enovix (ENVX)</td><td>12.4%</td><td>41.1%</td></tr><tr><td>Clene (CLNN)</td><td>12%</td><td>62.2%</td></tr><tr><td>Caledonia Mining (CMCL)</td><td>14.3%</td><td>29.6%</td></tr><tr><td>Better Home &amp; Finance Holding (BETR)</td><td>19.3%</td><td>104%</td></tr><tr><td>Astera Labs (ALAB)</td><td>10.8%</td><td>27.8%</td></tr><tr><td>AppLovin (APP)</td><td>27.4%</td><td>22.1%</td></tr></tbody></table></div><p>Click here to see the full list of 203 stocks from our Fast Growing US Companies With High Insider Ownership screener.</p><p>Here we highlight a subset of our preferred stocks from the screener.</p><h2>Viemed Healthcare (VMD)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Viemed Healthcare, Inc. operates in the United States offering home medical equipment and post-acute respiratory healthcare services, with a market cap of $372.90 million.</p><p><strong>Operations:</strong> The company generates revenue of $270.28 million from its Healthcare Facilities &amp; Services segment.</p><p><strong>Insider Ownership:</strong> 13.6%</p><p><strong>Earnings Growth Forecast:</strong> 27.8% p.a.</p><p>Viemed Healthcare demonstrates potential as a growth company with high insider ownership, evidenced by its robust earnings growth of 32.6% over the past year and forecasted revenue increase of 12.8% annually, surpassing the US market average. The company's strategic focus on organic growth and disciplined acquisitions was highlighted in recent announcements. Additionally, Viemed's new share repurchase program underscores confidence in its valuation, trading significantly below estimated fair value despite no substantial insider buying recently.</p><ul><li>Dive into the specifics of Viemed Healthcare here with our thorough growth forecast report.</li><li>Our valuation report unveils the possibility Viemed Healthcare's shares may be trading at a discount.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a2a6ac4a-d3ae-4743-a8ab-bf92331843a7/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a2a6ac4a-d3ae-4743-a8ab-bf92331843a7/chart/earnings-and-revenue-growth"/><figcaption>VMD Earnings and Revenue Growth as at Apr 2026</figcaption></figure><h2>Ramaco Resources (METC)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Ramaco Resources, Inc. is involved in the development, operation, and sale of metallurgical coal with a market cap of $886.58 million.</p><p><strong>Operations:</strong> The company's revenue is derived entirely from the metallurgical coal segment, totaling $536.62 million.</p><p><strong>Insider Ownership:</strong> 10.4%</p><p><strong>Earnings Growth Forecast:</strong> 93.4% p.a.</p><p>Ramaco Resources faces challenges with a net loss of US$51.45 million for 2025, down from a net income of US$11.19 million the previous year, and declining sales figures. Despite these setbacks, the company is trading significantly below its estimated fair value and is expected to become profitable within three years with earnings growth forecasted at 93.39% annually. However, legal issues related to class action lawsuits could impact investor sentiment despite no recent insider trading activity.</p><ul><li>Click here to discover the nuances of Ramaco Resources with our detailed analytical future growth report.</li><li>According our valuation report, there's an indication that Ramaco Resources' share price might be on the cheaper side.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b401923f-33a5-4c09-8deb-b067999fa26b/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b401923f-33a5-4c09-8deb-b067999fa26b/chart/earnings-and-revenue-growth"/><figcaption>METC Earnings and Revenue Growth as at Apr 2026</figcaption></figure><h2>Uxin (UXIN)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★★</p><p><strong>Overview:</strong> Uxin Limited is an investment holding company that operates as a used car retailer in the People's Republic of China, with a market cap of approximately $600 million.</p><p><strong>Operations:</strong> The company generates revenue primarily from its Internet Information Providers segment, amounting to CN¥3.24 billion.</p><p><strong>Insider Ownership:</strong> 35.7%</p><p><strong>Earnings Growth Forecast:</strong> 74.1% p.a.</p><p>Uxin's growth trajectory is underpinned by strategic expansions and a high level of insider ownership, which aligns management interests with shareholders. The company reported significant revenue growth for 2025, reaching CNY 3.24 billion, while narrowing its net loss to CNY 277.54 million. Uxin's forecasted annual revenue growth of 36% outpaces the US market average and supports its profitability outlook within three years. Recent leadership changes and strategic partnerships further bolster its expansion in China's automotive sector.</p><ul><li>Take a closer look at Uxin's potential here in our earnings growth report.</li><li>Insights from our recent valuation report point to the potential overvaluation of Uxin shares in the market.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/ownership-breakdown"/><figcaption>UXIN Ownership Breakdown as at Apr 2026</figcaption></figure><h2>Taking Advantage</h2><ul><li>Unlock more gems!  Our Fast Growing US Companies With High Insider Ownership screener has unearthed 200 more companies for you to explore.Click here to unveil our expertly curated list of 203 Fast Growing US Companies With High Insider Ownership.</li><li>Contemplating Other Strategies? AI is about to change healthcare. These 124 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders.      It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities.      All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p><div><h3><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>• Connect an unlimited number of Portfolios and see your total in one currency<br/>• Be alerted to new Warning Signs or Risks via email or mobile<br/>• Track the Fair Value of your stocks<br/></p><p>Try a Demo Portfolio for Free</p></div></div></div>

METCB

METC

UXIN

<p>The U.S. market has seen a 30% increase over the past year, with earnings expected to grow by 16% annually. Growth companies with high insider ownership are appealing, indicating strong internal confidence. Notable companies include Uxin (35.7% insider ownership, 74.1% earnings growth), Ramaco Resources (10.4% insider ownership, 93.4% earnings growth), and Viemed Healthcare (13.6% insider ownership, 27.8% earnings growth). These companies show potential for growth despite varying challenges, with insider ownership aligning management interests with shareholders.</p>

Three Insider-Favored Growth Companies With High Ownership